Active Computerized Pharmacovigilance Using Natural Language Processing, Statistics, and Electronic Health Records: A Feasibility Study

Journal of the American Medical Informatics Association

Volumn 16, Issue 3, 2009, Pages 328-337

  Wang, Xiaoyan ^a   Hripcsak, George ^a   Markatou, Marianthi ^a   Friedman, Carol ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IBUPROFEN; MORPHINE; PAROXETINE; ROSIGLITAZONE; WARFARIN;

ABSCESS; AGITATION; APPETITE DISORDER; ARTHRITIS; ARTICLE; BACTERIAL INFECTION; BULIMIA; CHILL; COLD SWEAT; COLIC; COMPUTER PROGRAM; CONFUSION; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTROLLED STUDY; COUGHING; CYANOSIS; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIZZINESS; DROWSINESS; DRUG ERUPTION; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DYSPNEA; ELECTRONIC MEDICAL RECORD; EMOTIONAL DISORDER; ENERGY METABOLISM; EPILEPSY; ERYTHEMA; ESOPHAGUS ACHALASIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FEASIBILITY STUDY; FEVER; GENERALIZED ANXIETY DISORDER; HALLUCINATION; HEADACHE; HEART ATRIUM ENLARGEMENT; HEART FAILURE; HEARTBURN; HEMOPTYSIS; HORMONE METABOLISM; HOT FLUSH; HUMAN; HYPERTENSION; HYPONATREMIA; INFORMATION PROCESSING; INSOMNIA; INTOXICATION; JOINT SWELLING; LETHARGY; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALINGERING; MEDICAL INFORMATION; MOOD DISORDER; MOTOR RETARDATION; MOUTH LESION; MUSCLE CRAMP; MYALGIA; NATURAL LANGUAGE PROCESSING; NAUSEA; NERVOUSNESS; NIGHT SWEAT; NIGHTMARE; OBSESSIVE COMPULSIVE DISORDER; OSTEOARTHRITIS; PAIN; PANIC; PARESTHESIA; PLEURAL PAIN; PRURITUS; RESTLESSNESS; RIGIDITY; SEIZURE; SENSORY DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOCIAL PHOBIA; SPUTUM; STANDING; STATISTICS; STOMACH PAIN; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SYNCOPE; TASTE DISORDER; THORAX PAIN; TINNITUS; TOBACCO DEPENDENCE; TREMOR; UNSPECIFIED SIDE EFFECT; URGE INCONTINENCE; VERTIGO; VISUAL HALLUCINATION; VOMITING; WEAKNESS; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; DRUG TOXICITY; FEASIBILITY STUDIES; HUMANS; INFORMATION STORAGE AND RETRIEVAL; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; NATURAL LANGUAGE PROCESSING; PHARMACEUTICAL PREPARATIONS; SOFTWARE; STATISTICS AS TOPIC;

EID: 65349157361     PISSN: 10675027     EISSN: None     Source Type: Journal    
DOI: 10.1197/jamia.M3028     Document Type: Article

References (57)

1. McBride W. Thalidomide and congential malformation. Lancet 2 (1961) 1238
2. Amery W.K. Why there is a need for pharmacovigilance. Pharmacoepidemiol Drug Saf 8 1 (1999) 61-64 Jan
3. Griffin J.P., and Pharmacovigilance J.R. Coll, Londres: Physician's 26 2 (1992) 197-198 Apr
4. http://www.emea.europa.eu/ Accessed 3/21/09
5. http://www.fda.gov/cder/aers/default.htm Accessed 3/21/09
6. Wood L., and Martinez C. The general practice research database: Role in pharmacovigilance. Drug Saf 27 12 (2004) 871-881
7. nd edn. (2007), Wiley
8. Wysowski D.K., and Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: The importance of reporting suspected reactions. Arch Intern Med 165 12 (2005) 1363-1369 Jun 27
9. Stephenson W.P., and Hauben M. Data mining for signals in spontaneous reporting databases: Proceed with caution. Pharmacoepidemiol Drug Saf 16 4 (2007) 359-365 Apr
10. Venulet J. Possible strategies for early recognition of potential drug safety problems. Adverse Drug React Acute Poisoning Rev 7 1 (1988) 39-47 Spring
11. Evans S.J., Waller P.C., and Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol drug Saf 10 6 (2001) 483-486 Oct-Nov
12. nd edn. GS (1998), Lippincott, Raven, PA
13. Hauben M., and Zhou X. Quantitative methods in pharmacovigilance: Focus on signal detection. Drug Saf 26 3 (2003) 159-186
14. http://www.who-umc.org/DynPage.aspx Accessed 3/21/09
15. http://yellowcard.mhra.gov.uk/ Accessed 3/21/09
16. Burwen D.R., LVL, Braun M.M., Houck P., and Ball R. Evaluating adverse events after vaccination in the Medicare population. Pharmacoepidemiol Drug Saf 16 7 (2007) 753-761 Jul
17. Banks D., WE, Burwen D.R., et al. Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf 14 9 (2005) 601-609 September
18. http://www.fda.gov/cdrh/MAUDE.html Accessed 3/21/09
19. Eland I.A., Belton K.J., van Grootheest A.C., et al. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 48 4 (1999) 623-627 Oct
20. Halpern S.D., Barton T.D., Gross R., et al. Epidemiologic studies of adverse effects of anti-retroviral drugs: How well is statistical power reported. Pharmacoepidemiol Drug Saf 14 3 (2005) 155-161 Mar
21. Coulter D.M. New Zealand Intensive Medicines Monitoring Programme, Pharmacoepidemiol d, Saf. Marine 7 2 (1998) 79-90
22. Evans J.M., McNaughton D., Donnan P.T., and MacDonald T.M. Pharmacoepidemiological research at the Medicines Monitoring Unit, Scotland: Data protection and confidentiality. Pharmacoepidemiol Drug Saf 10 7 (2001) 669-673 Dec
23. Gelfand J.M., Crawford G.H., Brod B.A., and Szazpary P.O. Adverse cutaneous reactions to guggulipid. J Am Acad Dermatol 52 3 Pt 1 (2005) 533-534 Mar
24. Waller P. Pharmacoepidemiology-A tool for public health. Pharmacoepidemiol Drug Saf 10 2 (2001) 165-172 Mar-Apr
25. HershmanD N.A., Jacobson J.S., et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 99 3 (2007) 96-205 Febr
26. Ray W.A., Murray K.T., Hall K., and Stein C.M. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 360 3 (2009) 225-235 Jan 15
27. Brown J.S., Kulldorff M., Chan K.A., et al. Early detection of adverse drug events within population-based health networks: Application of sequential testing methods. Pharmacoepidemiol Drug Saf 16 12 (2007) 1275-1284 Dec
28. Berlowitz D.R., Miller D.R., Oliveria S.A., et al. Differential associations of beta blockers with haemorrhagic events for chronic heart failure patients on warfarin. Pharmacoepidemiol Drug Saf 15 11 (2006) 799-807 Nov
29. Hauben M., Madigan D., Gerrits C.M., Walsh L., and Van Puijenbroek E.P. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 4 5 (2005) 929-948 September
30. Szarfman A., Machado S.G., and O'Neill R.T. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 25 6 (2002) 381-392
31. Hauben M. Application of an empiric Bayesian data mining algorithm to reports of pancreatitis associated with atypical antipsychotics. Pharmacotherapy 24 9 (2004) 1,122-9 September
32. DuMouchel W., Smith E.T., Beasley R., et al. Association of asthma therapy and Churg-Strauss syndrome: An analysis of postmarketing surveillance data. Clin Ther 26 7 (2004) 1092-1104 Jul
33. Baruch J.J. Progress in programming for processing English language medical records. Ann N Y Acad Sci 126 2 (1965) 795-804 Aug 6
34. Aronson A.R. Effective mapping of biomedical text to the UMLS metathesaurus: The MetaMap program. Proc AMIA Symp (2001) 17-21
35. Hahn U., Romacker M., and Schulz S. MEDSYNDIKATE-A natural language system for the extraction of medical information from findings reports. Int J Med Inform 67 1-3 (2002) 63-74 Dec 4
36. Friedman C., Shagina L., Lussier Y., and Hripcsak G. Automated encoding of clinical documents based on natural language processing. J Am Med Inform Assoc 11 5 (2004) 392-402 Sept-Oct
37. Chen L., and Friedman C. Extracting phenotypic information from the literature via natural language processing. Stud Health Technol Inform 107 2 (2004) 758-762
38. Rindflesch T.C., and Fiszman M. The interaction of domain knowledge and linguistic structure in natural language processing: Interpreting hypernymic propositions in biomedical text. J Biomed Inform 36 6 (2003) 462-477 Dec
39. Bates D.W., Evans R.S., Murff H., et al. Detecting adverse events using information technology. J Am Med Inform Assoc 10 2 (2003) 115-128 Mar-Apr
40. Honigman B., Lee J., Rothschild J., et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 8 3 (2001) 254-266 May-Jun
41. Rebholz-Schuhmann D., Kirsch H., Arregui M., et al. EBIMed-Text Crunching to Gather Facts for Proteins from MEDLINE. BioInformatics 23 2 (2007) e237-e244 Jan 15
42. Narayanasamy V., Mukhopadhyay S., Palakal M., Potter D.A., and Trans M. Mining transitive associations among biological objects from text. J Biomed Sci 11 6 (2004) 864-873 Nov-Dec
43. Cohen K.B., and Hunter L. Getting started in text mining. PLoS Comput Biol 4 1 (2008) e20 Jan
44. Rindflesch T.C., Tanabe L., Weinstein J.N., and Hunter L.E. Extraction of drugs, genes and relations from the biomedical literature. Pac Symp Biocomput (2000) 517-528
45. Cao H., Markatou M., Melton G.B., Chiang M.F., and Hripcsak G. Mining a clinical data warehouse to discover disease-finding associations using co-occurrence statistics. AMIA Annu Symp Proc (2005) 106-110
46. Cao H., Hripcsak G., and Markatou M. A statistical methodology for analyzing co-occurrence data from a large sample. J Biomed Inform 40 3 (2007) 343-352 Jun
47. Liu S.M.W., Moore R., et al. Prescription for electronic drug information exchange. IT Prof 7 5 (2005) 17-23
48. Chen E.S., Hripcsak G., Xu H., Markatou M., and Friedman C. Automated acquisition of disease drug knowledge from biomedical and clinical documents: An initial study. J Am Med Inform Assoc 15 1 (2008) 87-98 Jan-Feb
49. http://www.nlm.nih.gov/research/umls/ Accessed 3/21/09
50. http://www.micromedex.com/ Accessed 3/21/09
51. Chen E., Stetson P.D., Lussier Y.A., et al. Detection of practice pattern trends through natural language processing of clinical narratives and biomedical literature. AMIA Annu Symp Proc 11 (2007) 120-124
52. Wang X., Hripcsak G., and Friedman C. Characterizing environmental and phenotypic associations using information theory and electronic health records. AMIA Summit on Translational BioInformatics (2009)
53. Barnett O., Hoffer E., Feldman M., et al. 20 years later-What have we learned. AMIA Annu Symp Proc 6 (2008) 1201-1202
54. Parker R.C., and Miller R.A. Creation of realistic appearing simulated patient cases using the internist-1/QMR knowledge base and interrelationship properties of manifestations. Methods Inf Med 28 4 (1989) 346-351 Nov
55. Brown E.G. Using MedDRA: Implications for risk management. Drug Saf 27 8 (2004) 591-602
56. Bousquet C., Henegar C., LouetAL D.P., and Jaulent M.C. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach. Int J Med Inform 74 7-8 (2005) 563-571 Aug
57. Berry S.M., and Berry D.A. Accounting for multiplicities in assessing drug safety: A three-level hierarchical mixture model. Biometrics 60 2 (2004) 418-426 Jun